Skip to content

Monosomy 13q34 C4707797

Published: July 22, 2026Updated: August 20, 2026

A chromosomal condition where a portion of chromosome 13 is missing. It can cause developmental delays, distinctive facial features, and other health concerns. Care focuses on supportive management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital heart defect

Developmental delay

(neurological)

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intellectual disability

(neurological)

Facial dysmorphism

(congenital)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Chromosomal Monitoring

Regular surveillance including blood counts, bone marrow assessments, and imaging to detect progression or complications associated with monosomy 13q34.

monitoring
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Genetic Counseling and Family Support

Professional genetic counseling for patients and families to understand inheritance patterns, recurrence risks, and available reproductive options.

psychological

Additional treatment options

Corrective Surgical Interventions

Surgical management of structural abnormalities associated with 13q deletion syndrome including congenital heart defects, cleft palate repair, or other anatomic corrections as needed.

surgical

Symptomatic Pharmacological Management

Targeted medication therapy addressing specific manifestations such as seizure management, hormone replacement for endocrine deficiencies, or treatment of associated conditions.

medication

Multidisciplinary Supportive Care

Integrative approach including occupational therapy, speech therapy, and developmental support services to maximize functional abilities and quality of life.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Monosomy 13q34 C4707797?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Monosomy 13q34 C4707797. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy